Joerg Ermann, MD
Brigham and Women's Hospital
Boston, MA, United States
Disclosure(s): Augurex: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Johnson & Johnson: Consultant (Ongoing); Novartis: Grant/Research Support (Terminated, December 31, 2024)
Rouhin Sen, MD,MS
University of Alabama Birmingham
Birmingham, Alabama, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Grant Louie, MD, MHS
Arthritis and Rheumatism Associates, PC
Wheaton, Maryland, United States
Disclosure information not submitted.
Lesley Jackson, MD, MPH
University of Alabama at Birmingham
Vestavia, AL, United States
Disclosure information not submitted.
Despite use of MRI, the diagnosis of axial spondyloarthritis (AxSpA) remains a challenge due to the common presentation of back pain and the non-specific nature of MRI findings indicative of AxSpA. In addition, there are unique considerations with respect to the interpretation of imaging findings in the pediatric population that rheumatologists need to consider in interpreting studies. Classification criteria for AxSpA differ between pediatric and adult patients. Finally, there are many mimics of AxSpA that the clinician needs to consider when evaluating patients with back pain.
Speaker: Pamela Weiss, MD – Childrens Hospital of Philadelphia
Speaker: Walter P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta
Speaker: Lianne S. Gensler, MD – University of California San Francisco